Company profile for ARMO BioSciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors. Our robust pipeline includes validated product candidates aimed at treating a variety of cancers in combination with standard of care and emerging immunotherapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
575 Chesapeake Drive Redwood City, CA 94063
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Lilly cans pancreatic cancer program for Armo buyout drug
Lilly cans pancreatic cancer program for Armo buyout drug

24 Oct 2019

// A. Al Idrus FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/after-phase-3-bust-lilly-bids-armo-buyout-drug-adieu

A. Al Idrus FIERCE BIOTECH
24 Oct 2019
Lilly's Armo buyout drug a bust in pancreatic cancer
Lilly's Armo buyout drug a bust in pancreatic cancer

17 Oct 2019

// Ben Adams FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/lilly-s-armo-buyout-drug-a-bust-pancreatic-cancer

Ben Adams FIERCE BIOTECH
17 Oct 2019
Sanofi doubles down on Biontech
Sanofi doubles down on Biontech

04 Jan 2019

// Madeleine Armstrong EVALUATE

http://www.evaluate.com/vantage/articles/news/deals/sanofi-doubles-down-biontech?mkt_tok=eyJpIjoiWlRVeE9URXpNekk1TlRkaiIsInQiOiJET3ZmaUllSlFXTU5nZHFQcFk5Z0pva1RLYTVuUU9yblwvc21hVTAzSFFJMzVWSG1hSVFwdG1xQSswdnQwaHJSWWJreFh5S2thZGVnNHhcL3NnK2lMYUxSRjNcL1wveEtRN3kyMTZ6VXBUUE5QUVpvWHhUcDJLZElwcGpHN3RTbU5cL2h6In0%3D

Madeleine Armstrong EVALUATE
04 Jan 2019

https://www.reuters.com/article/us-lilly-m-a/lilly-to-consider-more-acquisitions-like-16-billion-armo-buy-idUSKCN1NB1UT

REUTERS
06 Nov 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty